Search Results

There are 130816 results for: content related to: Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry

  1. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  2. Docetaxel Nanotechnology in Anticancer Therapy


    Volume 7, Issue 6, June 2012, Pages: 952–972, Pengxiang Zhao and Didier Astruc

    Version of Record online : 19 APR 2012, DOI: 10.1002/cmdc.201200052

  3. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x

  4. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity

    The Prostate

    Volume 72, Issue 6, 1 May 2012, Pages: 661–667, Peter Makhov, Konstantin Golovine, Daniel Canter, Alexander Kutikov, Jay Simhan, Melany M. Corlew, Robert G. Uzzo and Vladimir M. Kolenko

    Version of Record online : 27 JUL 2011, DOI: 10.1002/pros.21469

  5. Docetaxel-Associated Epiphora

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 6, June 2006, Pages: 853–867, Dr. Polly E. Kintzel, Dr. Laura B. Michaud and Dr. Marianne K. Lange

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.6.853

  6. Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

    The Journal of Gene Medicine

    Volume 12, Issue 6, June 2010, Pages: 516–527, Xiong Li, Youhong Liu, Yong Tang, Phipps Roger, Meei-Huey Jeng and Chinghai Kao

    Version of Record online : 17 MAY 2010, DOI: 10.1002/jgm.1462

  7. You have free access to this content
    Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E635–E640, Matthias M. Heck, Mark Thalgott, Margitta Retz, Petra Wolf, Tobias Maurer, Roman Nawroth, Georgios Hatzichristodoulou, Jürgen E. Gschwend and Hubert Kübler

    Version of Record online : 13 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11364.x

  8. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 856–867, J.Y. Henry, L. Lu, M. Adams, B. Meyer, J.B. Bartlett, Prof. A.G. Dalgleish and C. Galustian

    Version of Record online : 3 OCT 2011, DOI: 10.1002/pros.21488

  9. From Mouse to Man: Predictions of Human Pharmacokinetics of Orally Administered Docetaxel From Preclinical Studies

    The Journal of Clinical Pharmacology

    Volume 52, Issue 3, March 2012, Pages: 370–380, Mr S. L. W. Koolen, Dr R. A. B. van Waterschoot, Dr O. van Tellingen, Dr A. H. Schinkel, Dr J. H. Beijnen, Dr J. H. M. Schellens and Dr A. D. R. Huitema

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010397051

  10. You have free access to this content
    The effect of Echinacea purpurea on the pharmacokinetics of docetaxel

    British Journal of Clinical Pharmacology

    Volume 76, Issue 3, September 2013, Pages: 467–474, Andrew K. L. Goey, Irma Meijerman, Hilde Rosing, Jacobus A. Burgers, Marja Mergui-Roelvink, Marianne Keessen, Serena Marchetti, Jos H. Beijnen and Jan H. M. Schellens

    Version of Record online : 20 AUG 2013, DOI: 10.1111/bcp.12159

  11. Host Cell and Malarial Targets for Docetaxel (Taxotere™) during the Erythrocytic Development of Plasmodium falciparum

    Journal of Eukaryotic Microbiology

    Volume 45, Issue 2, March 1998, Pages: 171–183, Veronique Sinou, Yves Boulard, Philippe Grellier and Joseph Schrevel

    Version of Record online : 2 MAY 2007, DOI: 10.1111/j.1550-7408.1998.tb04522.x

  12. Pharmacogenetic Pathway Analysis of Docetaxel Elimination

    Clinical Pharmacology & Therapeutics

    Volume 85, Issue 2, February 2009, Pages: 155–163, SD Baker, J Verweij, GA Cusatis, RH van Schaik, S Marsh, SJ Orwick, RM Franke, S Hu, EG Schuetz, V Lamba, WA Messersmith, AC Wolff, MA Carducci and A Sparreboom

    Version of Record online : 28 MAY 2008, DOI: 10.1038/clpt.2008.95

  13. Survival analysis of platinum-refractory patients with advanced esophageal cancer treated with docetaxel or best supportive care alone: a retrospective study

    Diseases of the Esophagus

    Volume 27, Issue 8, November/December 2014, Pages: 737–743, T. Moriwaki, T. Kajiwara, T. Matsumoto, H. Suzuki, Y. Hiroshima, K. Matsuda, S. Hirai, Y. Yamamoto, T. Yamada, A. Sugaya, M. Kobayashi, S. Endo, K. Ishige, T. Nishina and I. Hyodo

    Version of Record online : 11 JUN 2014, DOI: 10.1111/dote.12246

  14. Phase II study of oral docetaxel and cyclosporine in canine epithelial cancer

    Veterinary and Comparative Oncology

    Volume 12, Issue 2, June 2014, Pages: 160–168, A. Waite, C. Balkman, D. Bailey, M. Kiselow, A. Flory, B. B. Beaulieu, L. D. Lewis and M. McEntee

    Version of Record online : 21 AUG 2012, DOI: 10.1111/j.1476-5829.2012.00350.x

  15. You have free access to this content
    Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 974–978, Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill and Philippe Beuzeboc

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09296.x

  16. You have free access to this content
    Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer

    BJU International

    Volume 115, Issue 5, May 2015, Pages: 744–752, Stéphane Oudard, Gero Kramer, Orazio Caffo, Lorraine Creppy, Yohan Loriot, Steinbjoern Hansen, Mats Holmberg, Frederic Rolland, Jean-Pascal Machiels and Michael Krainer

    Version of Record online : 29 DEC 2014, DOI: 10.1111/bju.12845

  17. You have free access to this content
    Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)

    BJU International

    Volume 116, Issue 1, July 2015, Pages: 17–29, Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh and Andrew J. Armstrong

    Version of Record online : 23 OCT 2014, DOI: 10.1111/bju.12867

  18. Functional p53 determines docetaxel sensitivity in prostate cancer cells

    The Prostate

    Volume 73, Issue 4, March 2013, Pages: 418–427, Chengfei Liu, Yezi Zhu, Wei Lou, Nagalakshmi Nadiminty, Xinbin Chen, Qinghua Zhou, Xu Bao Shi, Ralph W. deVere White and Allen C. Gao

    Version of Record online : 19 SEP 2012, DOI: 10.1002/pros.22583

  19. A mutation in β-tubulin and a sustained dependence on androgen receptor signalling in a newly established docetaxel-resistant prostate cancer cell line

    Cell Biology International

    Volume 34, Issue 2, February 2010, Pages: 177–184, Takahito Hara, Kazutaka Ushio, Mayumi Nishiwaki, Jin Kouno, Hideo Araki, Yukiko Hikichi, Masahiko Hattori, Yumi Imai and Masuo Yamaoka

    Version of Record online : 2 JAN 2013, DOI: 10.1042/CBI20090030

  20. You have free access to this content
    Optimizing pharmacokinetic bridging studies in paediatric oncology using physiologically-based pharmacokinetic modelling: application to docetaxel

    British Journal of Clinical Pharmacology

    Volume 80, Issue 3, September 2015, Pages: 534–547, Hoai-Thu Thai, Florent Mazuir, Sylvaine Cartot-Cotton and Christine Veyrat-Follet

    Version of Record online : 14 AUG 2015, DOI: 10.1111/bcp.12702